Answers are grounded in this paper and cite their sources.
Loss to follow-up (LTFU) after newborn hearing screening (NHS) is a persistent, internationally documented barrier to diagnosis and intervention. This cohort study evaluated diagnostic follow-up after NHS among well infants at a tertiary hospital in Jordan (February 2024–February 2025) and examined factors associated with initial OAE referral. Well newborns underwent otoacoustic emission (OAE) screening at birth; those who did not pass were scheduled for repeat OAE at 2 weeks and diagnostic auditory brainstem response (ABR) evaluation at 2 months when indicated. Among 1074 screened infants, 100 (9.3%) did not pass initial OAE, and 26 (26.0%) returned for repeat testing (LTFU = 74.0%). Of 57 infants meeting criteria for diagnostic ABR, 3 (5.3%) completed evaluation (LTFU = 94.7%); no tested factor predicted initial OAE referral, and ABR- LTFU predictors could not be analyzed. Most families with incomplete evaluation (72%) could not be reached because contact information recorded at screening was inaccurate or outdated; barriers among families reached included perceived normal hearing, financial constraints, and difficulty accessing the clinic. Although poor diagnostic follow-up is a documented challenge across high-, middle-, and low-income settings, the LTFU observed here (74.0–94.7%) was higher than international averages and comparable to the upper range reported among programs lacking systemic tracking infrastructure, underscoring the absence of a dedicated follow-up and recall system as the primary driver. Establishing centralized data tracking, structured recall procedures, and parental education are essential to closing this gap.
No takes yet. Share an insight, caveat, or question.
Zuriekat et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: